According to a new report Global Blood Purification Equipment Market, published by KBV research, The Global Blood Purification Equipment Market size is expected to reach $19.2 billion by 2026, rising at a market growth of 5.3% CAGR during the forecast period.
In 2019, Asia-Pacific emerged as the leading region of the global market. The region also displays various attractive growth possibilities for the players working in the blood purification equipment market. This is due to the massive population of the region combined with the various lifestyle & chronic diseases and high rates of ESRDs. The North America market is estimated to grow at a CAGR of 4.3% during (2020 - 2026). Additionally, The Europe market would showcase a CAGR of 4.8% during (2020 - 2026).
In 2019, the dialysis centers emerged as a dominating segment in the end-user segment. This development is owing to the patient's inclinations to get dialysis treatments with the help of services offered by dialysis centers. The major benefit of in-center dialysis is that an individual doesn’t need any medical training because the healthcare experts perform most of the tasks which makes it convenient for patients by preventing any errors at the time of treatment.
The portable segment would exhibit a promising growth rate during the forecast period. This is significantly due to the benefits provided by portable blood purification equipment like low space usage & ease of movement, particularly in critical care units. Therefore, healthcare experts extensively adopt & prefer this equipment in order to treat patients, hence supporting the growth of the market. The Stationary market is expected to witness a CAGR of 5.8% during (2020 - 2026).
Full Report: https://www.kbvresearch.com/blood-purification-equipment-market/
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of B. Braun Melsungen AG, Baxter International, Inc., Asahi Kasei Corporation, Nikkiso Co., Ltd., Kaneka Corporation, Cerus Corporation, Shanwaishan Medical Group, Jafron Biomedical Co., Ltd., Infomed SA, and Fresenius SE & Co. KGaA.
By Product
By Indication
By End User
By Geography
Companies Profiled
Unique Offerings from KBV Research
Unique Offerings 
